Corpus ID: 80609134

Characterising novel phosphatase enzymes important in regulating androgen receptor function in the progression of castrate resistant prostate cancer

@inproceedings{Grey2017CharacterisingNP,
  title={Characterising novel phosphatase enzymes important in regulating androgen receptor function in the progression of castrate resistant prostate cancer},
  author={James Grey},
  year={2017}
}
..................................................................................................................................... 2 Acknowledgement ...................................................................................................................... 4 Abbreviations ............................................................................................................................ 11 List of Figures and Tables… Expand

References

SHOWING 1-10 OF 364 REFERENCES
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.
  • G. Attard, A. Reid, +16 authors J. D. de Bono
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2009
Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.
Contribution of the Androgen Receptor to Prostate Cancer Predisposition and Progression
Regulation of the androgen receptor by SET9-mediated methylation
Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?
AR-v7 protein expression is regulated by protein kinase and phosphatase
...
1
2
3
4
5
...